Safer Alternative to Cyclophosphamide at Hand for ILD?

(MedPage Today) -- PHILADELPHIA -- Rituximab (Rituxan) matched IV cyclophosphamide for improving lung function in patients with interstitial lung disease (ILD) related to systemic sclerosis and other connective tissue diseases, and was associated...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news